{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:47:15Z","timestamp":1790128035768,"version":"4.0.1"},"reference-count":190,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Endometriosis (EM) is a chronic disease characterized by the presence and proliferation of functional endometrial glands and stroma outside the uterine cavity. Ovaries and pelvic peritoneum are the most common locations for endometrial ectopic tissue, followed by deep infiltrating EM sites. The cyclic and recurrent bleeding, the progressive fibrosis and the peritoneal adhesions of ectopic endometrial glands, may cause different symptoms depending on the origin involved. EM is a frequent clinical condition affecting around 10% of women of mainly reproductive age, as well as in post-menopausal women and adolescents, especially with uterine anomalies. The risk of developing EM depends on a complex interaction between genetic, immunological, hormonal, and environmental factors. It is largely considered to arise due to a dysfunction of immunological surveillance. In fact, women with EM exhibit altered functions of peritoneal macrophages, lymphocytes and natural killer cells, as well as levels of inflammatory mediators and growth factors in the peritoneal fluid. In EM patients, peritoneal macrophages are preponderant and highly active compared to healthy women. Peritoneal macrophages are able to regulate the events that determine the production of cytokines, prostaglandins, growth factors and complement components. Several studies have shown alteration in the regulation of the complement activation, leading to chronic inflammation characteristic of EM. Aberrant regulation\/activation of the complement system has been observed in the peritoneal cavity of women affected by EM. Thus, complement inhibition may represent a new approach for the treatment of EM, given that a number of complement inhibitors are under pre-clinical and clinical development. Such an intervention may provide a broader therapeutic control of complement-mediated inflammatory damage in EM patients. This review will focus on our current understanding of the role of complement activation in EM and possible modalities available for complement-based therapy.<\/jats:p>","DOI":"10.3389\/fimmu.2020.599117","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T20:30:10Z","timestamp":1610483410000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":95,"title":["Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target"],"prefix":"10.3389","volume":"11","author":[{"given":"Chiara","family":"Agostinis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Balduit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mangogna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Zito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday","family":"Kishore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-018-0008-5","article-title":"Endometriosis","volume":"4","author":"Zondervan","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1810764","article-title":"Endometriosis","volume":"382","author":"Zondervan","year":"2020","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/242149","article-title":"Endometriosis: a disease that remains enigmatic","volume":"2013","author":"Acien","year":"2013","journal-title":"ISRN Obstet Gynecol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bpobgyn.2018.06.001","article-title":"Risk for and consequences of endometriosis: A critical epidemiologic review","volume":"51","author":"Shafrir","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1597121","article-title":"Endometriosis in the Adolescent Patient","volume":"35","author":"Stuparich","year":"2017","journal-title":"Semin Reprod Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.12688\/f1000research.14817.1","article-title":"Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment","volume":"8","author":"Rolla","year":"2019","journal-title":"F1000Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/0974-2727.66699","article-title":"Endometriosis - morphology, clinical presentations and molecular pathology","volume":"2","author":"Agarwal","year":"2010","journal-title":"J Lab Phys"},{"key":"B8","article-title":"Endometriosis still a challenge","volume":"7","author":"Mehedintu","year":"2014","journal-title":"J Med Life"},{"key":"B9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev-pathmechdis-012419-032654","article-title":"The Origin and Pathogenesis of Endometriosis","volume":"15","author":"Wang","year":"2020","journal-title":"Annu Rev Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2855","article-title":"Cutting SRC-1 down to size in endometriosis","volume":"18","author":"Dyson","year":"2012","journal-title":"Nat Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.3390\/ijms20225615","article-title":"The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights","volume":"20","author":"Lagana","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.12659\/msm.881707","article-title":"Is abnormal eutopic endometrium the cause of endometriosis? The role of eutopic endometrium in pathogenesis of endometriosis","volume":"17","author":"Liu","year":"2011","journal-title":"Med Sci Monit"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2804","article-title":"Hematogenous Dissemination of Mesenchymal Stem Cells from Endometriosis","volume":"36","author":"Li","year":"2018","journal-title":"Stem Cells"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/1933719110397210","article-title":"Endometrial stromal cells and immune cell populations within lymph nodes in a nonhuman primate model of endometriosis","volume":"18","author":"Hey-Cunningham","year":"2011","journal-title":"Reprod Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1095\/biolreprod.114.124313","article-title":"The role of the lymphatic system in endometriosis: a comprehensive review of the literature","volume":"92","author":"Jerman","year":"2015","journal-title":"Biol Reprod"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(91)90254-o","article-title":"A reappraisal of the coelomic metaplasia theory by reviewing endometriosis occurring in unusual sites and instances","volume":"165","author":"Suginami","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/igc.0b013e3181ca2290","article-title":"Intraperitoneal dissemination of endometrial cancer cells after hysteroscopy: a systematic review and meta-analysis","volume":"20","author":"Polyzos","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4103\/0970-9371.71877","article-title":"Scar endometriosis","volume":"27","author":"Pathan","year":"2010","journal-title":"J Cytol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1586\/eci.11.53","article-title":"Immune interactions in endometriosis","volume":"7","author":"Herington","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2018.07.004","article-title":"The Immunopathophysiology of Endometriosis","volume":"24","author":"Symons","year":"2018","journal-title":"Trends Mol Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.10.013","article-title":"Pathogenesis of endometriosis: the genetic\/epigenetic theory","volume":"111","author":"Koninckx","year":"2019","journal-title":"Fertil Steril"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12577","article-title":"Implications of immune dysfunction on endometriosis associated infertility","volume":"8","author":"Miller","year":"2017","journal-title":"Oncotarget"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/795976","article-title":"Pathophysiology and Immune Dysfunction in Endometriosis","volume":"2015","author":"Ahn","year":"2015","journal-title":"BioMed Res Int"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2009.081011","article-title":"Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease","volume":"175","author":"Bacci","year":"2009","journal-title":"Am J Pathol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.0001-6349.2004.00229.x","article-title":"Higher activity by opaque endometriotic lesions than nonopaque lesions","volume":"83","author":"Khan","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/s0015-0282(16)56456-5","article-title":"Monocyte-mediated enhancement of endometrial cell proliferation in women with endometriosis","volume":"61","author":"Braun","year":"1994","journal-title":"Fertil Steril"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-235804","article-title":"Impaired NK-cell migration in WAS\/XLT patients: role of Cdc42\/WASp pathway in the control of chemokine-induced beta2 integrin high-affinity state","volume":"115","author":"Stabile","year":"2010","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2010.01.003","article-title":"Oestrogen and progesterone regulation of inflammatory processes in the human endometrium","volume":"120","author":"King","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/humupd\/6.1.28","article-title":"Uterine leukocytes and decidualization","volume":"6","author":"King","year":"2000","journal-title":"Hum Reprod Update"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12259","article-title":"Characterization of uterine NK cells in women with infertility or recurrent pregnancy loss and associated endometriosis","volume":"72","author":"Giuliani","year":"2014","journal-title":"Am J Reprod Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/aji.12486","article-title":"Increased uNK Progenitor Cells in Women With Endometriosis and Infertility are Associated With Low Levels of Endometrial Stem Cell Factor","volume":"75","author":"Thiruchelvam","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3109\/00016349309013364","article-title":"Changes of peripheral blood lymphocyte subsets before and after operation of patients with endometriosis","volume":"72","author":"Kikuchi","year":"1993","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2004.00224.x","article-title":"Increased numbers of activated mast cells in endometriosis lesions positive for corticotropin-releasing hormone and urocortin","volume":"52","author":"Kempuraj","year":"2004","journal-title":"Am J Reprod Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-0774.2003.tb00146.x","article-title":"Role of immunoreactions and mast cells in pathogenesis of human endometriosis\u2013morphologic study and gene expression analysis","volume":"16","author":"Konno","year":"2003","journal-title":"Hum Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2005.00254.x","article-title":"Increase of activated mast cells in human endometriosis","volume":"53","author":"Sugamata","year":"2005","journal-title":"Am J Reprod Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2006.03.057","article-title":"Pain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis","volume":"86","author":"Anaf","year":"2006","journal-title":"Fertil Steril"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2012.661415","article-title":"Mast cells in endometriosis: guilty or innocent bystanders","volume":"16","author":"Kirchhoff","year":"2012","journal-title":"Expert Opin Ther Targets"},{"key":"B38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10735-014-9595-y","article-title":"The intricate role of mast cell proteases and the annexin A1-FPR1 system in abdominal wall endometriosis","volume":"46","author":"Paula","year":"2015","journal-title":"J Mol Histol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.iac.2018.04.011","article-title":"Mast Cell Mediators of Significance in Clinical Practice in Mastocytosis","volume":"38","author":"Butterfield","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01543","article-title":"Mast Cells in Peritoneal Fluid From Women With Endometriosis and Their Possible Role in Modulating Sperm Function","volume":"10","author":"Borelli","year":"2019","journal-title":"Front Physiol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1998.tb00420.x","article-title":"Increased mast cell density in peritoneal endometriosis compared with eutopic endometrium with endometriosis","volume":"40","author":"Matsuzaki","year":"1998","journal-title":"Am J Reprod Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.7.6665","article-title":"Localization in tissues and secretion of eotaxin by cells from normal endometrium and endometriosis","volume":"85","author":"Hornung","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2002.tb02770.x","article-title":"Local cytokines in endometrial tissue: the role of interleukin-8 in the pathogenesis of endometriosis","volume":"955","author":"Arici","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2004.07.020","article-title":"Vascular endothelial growth factor A and C gene expression in endometriosis","volume":"35","author":"Takehara","year":"2004","journal-title":"Hum Pathol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/jog.13559","article-title":"Involvement of immune cells in the pathogenesis of endometriosis","volume":"44","author":"Izumi","year":"2018","journal-title":"J Obstet Gynaecol Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12540","article-title":"Neutrophil depletion reduces endometriotic lesion formation in mice","volume":"76","author":"Takamura","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"B47","article-title":"Endometriosis and autologous lymphocyte activation by endometrial cells. Are lymphocytes or endometrial cell defects responsible","volume":"42","author":"Helvacioglu","year":"1997","journal-title":"J Reprod Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(81)90598-6","article-title":"Deficient cellular immunity in endometriosis","volume":"141","author":"Dmowski","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0897.2010.00887.x","article-title":"Lymphocytes in endometriosis","volume":"65","author":"Osuga","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)55560-5","article-title":"In vitro lymphocyte activity in women with endometriosis\u2013an altered immune response","volume":"58","author":"Gilmore","year":"1992","journal-title":"Fertil Steril"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1984.tb00106.x","article-title":"Immunologic aspects of human endometriosis","volume":"6","author":"Steele","year":"1984","journal-title":"Am J Reprod Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1993.tb00623.x","article-title":"Recombinant interleukin-2 corrects in vitro the immunological defect of endometriosis","volume":"30","author":"Melioli","year":"1993","journal-title":"Am J Reprod Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1600-0897.1994.tb00843.x","article-title":"Flow cytometry analysis of lymphocyte subpopulations in peritoneal fluid of women with endometriosis","volume":"31","author":"Oosterlynck","year":"1994","journal-title":"Am J Reprod Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/del516","article-title":"Endometriosis: an inflammatory disease with a Th2 immune response component","volume":"22","author":"Podgaec","year":"2007","journal-title":"Hum Reprod"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-0749","article-title":"Interleukin (IL)-17A stimulates IL-8 secretion, cyclooxygensase-2 expression, and cell proliferation of endometriotic stromal cells","volume":"149","author":"Hirata","year":"2008","journal-title":"Endocrinology"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1985.tb00314.x","article-title":"Antiendometrial antibodies in patients with endometriosis","volume":"8","author":"Wild","year":"1985","journal-title":"Am J Reprod Immunol Microbiol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jri.2017.04.003","article-title":"What do we know about regulatory T cells and endometriosis? A systematic review","volume":"120","author":"de Barros","year":"2017","journal-title":"J Reprod Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1615\/critrevimmunol.v30.i1.30","article-title":"Role of complement in innate immunity and infections","volume":"30","author":"Daha","year":"2010","journal-title":"Crit Rev Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000633","article-title":"Complement, infection, and autoimmunity","volume":"31","author":"Conigliaro","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2007.09.008","article-title":"Role of complement and complement regulators in the removal of apoptotic cells","volume":"45","author":"Trouw","year":"2008","journal-title":"Mol Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3858","article-title":"Novel mechanisms and functions of complement","volume":"18","author":"Hajishengallis","year":"2017","journal-title":"Nat Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104123441506","article-title":"Complement. Second of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00592","article-title":"C1 Complex: An Adaptable Proteolytic Module for Complement and Non-Complement Functions","volume":"8","author":"Lu","year":"2017","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2013.08.001","article-title":"Overview of complement activation and regulation","volume":"33","author":"Noris","year":"2013","journal-title":"Semin Nephrol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2010.00149","article-title":"New insights of an old defense system: structure, function, and clinical relevance of the complement system","volume":"17","author":"Ehrnthaller","year":"2011","journal-title":"Mol Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0b013e32834253df","article-title":"The lectin pathway and its implications in coagulation, infections and auto-immunity","volume":"16","author":"Degn","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2014.00148","article-title":"The lectin pathway of complement and rheumatic heart disease","volume":"2","author":"Beltrame","year":"2014","journal-title":"Front Pediatr"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1084\/jem.176.6.1497","article-title":"Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease","volume":"176","author":"Matsushita","year":"1992","journal-title":"J Exp Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/386506a0","article-title":"A second serine protease associated with mannan-binding lectin that activates complement","volume":"386","author":"Thiel","year":"1997","journal-title":"Nature"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(01)00161-3","article-title":"MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway","volume":"15","author":"Dahl","year":"2001","journal-title":"Immunity"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902388","article-title":"MAp44, a human protein associated with pattern recognition molecules of the complement system and regulating the lectin pathway of complement activation","volume":"183","author":"Degn","year":"2009","journal-title":"J Immunol"},{"key":"B74","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.162.6.3481","article-title":"Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene","volume":"162","author":"Stover","year":"1999","journal-title":"J Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202588109","article-title":"Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2","volume":"109","author":"Heja","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1078\/0171-2985-00146","article-title":"The mannan-binding lectin-associated serine proteases (MASPs) and MAp19: four components of the lectin pathway activation complex encoded by two genes","volume":"205","author":"Schwaeble","year":"2002","journal-title":"Immunobiology"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100280","article-title":"The role of mannose-binding lectin-associated serine protease-3 in activation of the alternative complement pathway","volume":"187","author":"Iwaki","year":"2011","journal-title":"J Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(87)90011-3","article-title":"Regulation of the alternative pathway of human complement by C1q","volume":"24","author":"Fishelson","year":"1987","journal-title":"Mol Immunol"},{"key":"B79","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.132.3.1430","article-title":"Characterization of the initial C3 convertase of the alternative pathway of human complement","volume":"132","author":"Fishelson","year":"1984","journal-title":"J Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00530","article-title":"Assessment of the Role of C3(H2O) in the Alternative Pathway","volume":"11","author":"Fromell","year":"2020","journal-title":"Front Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.3.1305","article-title":"The central role of the alternative complement pathway in human disease","volume":"176","author":"Thurman","year":"2006","journal-title":"J Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12466","article-title":"Properdin: a tightly regulated critical inflammatory modulator","volume":"274","author":"Blatt","year":"2016","journal-title":"Immunol Rev"},{"key":"B83","doi-asserted-by":"publisher","first-page":"20160221","DOI":"10.1098\/rstb.2016.0221","article-title":"The mystery behind membrane insertion: a review of the complement membrane attack complex","volume":"372","author":"Bayly-Jones","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12475","article-title":"Protection of host cells by complement regulators","volume":"274","author":"Schmidt","year":"2016","journal-title":"Immunol Rev"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2013.06.001","article-title":"Complement factor H related proteins (CFHRs)","volume":"56","author":"Skerka","year":"2013","journal-title":"Mol Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1994.tb06256.x","article-title":"Clusterin: modulation of complement function","volume":"97","author":"Tschopp","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"B87","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.151.4.2159","article-title":"Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9","volume":"151","author":"Tschopp","year":"1993","journal-title":"J Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1084\/jem.170.3.637","article-title":"CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells","volume":"170","author":"Davies","year":"1989","journal-title":"J Exp Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1084\/jem.106.2.327","article-title":"Some properties of an esterase derived from preparations of the first component of complement","volume":"106","author":"Ratnoff","year":"1957","journal-title":"J Exp Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2011.04.004","article-title":"Complement factor I in health and disease","volume":"48","author":"Nilsson","year":"2011","journal-title":"Mol Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1084\/jem.153.5.1138","article-title":"Complement receptor is an inhibitor of the complement cascade","volume":"153","author":"Iida","year":"1981","journal-title":"J Exp Med"},{"key":"B92","article-title":"Structure and function of decay accelerating factor CD55","volume":"123","author":"Nicholson-Weller","year":"1994","journal-title":"J Lab Clin Med"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.09.040191.002243","article-title":"Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster","volume":"9","author":"Liszewski","year":"1991","journal-title":"Annu Rev Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2418-4","article-title":"Complement factor H in host defense and immune evasion","volume":"74","author":"Parente","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"B95","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00281-017-0663-8","article-title":"Diseases of complement dysregulation-an overview","volume":"40","author":"Wong","year":"2018","journal-title":"Semin Immunopathol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1097\/00003081-198023030-00018","article-title":"Endometriosis: can it produce an autoimmune response resulting in infertility","volume":"23","author":"Weed","year":"1980","journal-title":"Clin Obstet Gynecol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(87)90194-3","article-title":"Immunoproteins in the endometrium: clinical correlates of the presence of complement fractions C3 and C4","volume":"156","author":"Bartosik","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1530\/REP-17-0092","article-title":"High-throughput mRNA sequencing of stromal cells from endometriomas and endometrium","volume":"154","author":"Rekker","year":"2017","journal-title":"Reproduction"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-1338","article-title":"Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer","volume":"20","author":"Suryawanshi","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.24620","article-title":"Serum biomarker for diagnosis of endometriosis","volume":"229","author":"Signorile","year":"2014","journal-title":"J Cell Physiol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.06.001","article-title":"Single-nucleotide polymorphisms in the lysyl oxidase-like protein 4 and complement component 3 genes are associated with increased risk for endometriosis and endometriosis-associated infertility","volume":"96","author":"Ruiz","year":"2011","journal-title":"Fertil Steril"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a138768","article-title":"Investigations on the cell type responsible for the endometrial secretion of complement component 3 (C3)","volume":"9","author":"Bischof","year":"1994","journal-title":"Hum Reprod"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-69-5-1003","article-title":"Production and secretion of complement component 3 by endometriotic tissue","volume":"69","author":"Isaacson","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(97)00254-9","article-title":"Increased expression of complement component 3 in human ectopic endometrium compared with the matched eutopic endometrium","volume":"68","author":"Tao","year":"1997","journal-title":"Fertil Steril"},{"key":"B105","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0015-0282(16)54135-1","article-title":"The effect of estradiol on the production and secretion of complement component 3 by the rat uterus and surgically induced endometriotic tissue","volume":"55","author":"Isaacson","year":"1991","journal-title":"Fertil Steril"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)54960-7","article-title":"Evaluation of endometrial tissue specific complement activation in women with endometriosis","volume":"57","author":"D\u2019Cruz","year":"1992","journal-title":"Fertil Steril"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2007.02.006","article-title":"Complement and coagulation: strangers or partners in crime","volume":"28","author":"Markiewski","year":"2007","journal-title":"Trends Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.8.5543","article-title":"Hematin promotes complement alternative pathway-mediated deposition of C3 activation fragments on human erythrocytes: potential implications for the pathogenesis of anemia in malaria","volume":"179","author":"Pawluczkowycz","year":"2007","journal-title":"J Immunol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00281-017-0661-x","article-title":"The properdin pathway: an \u201calternative activation pathway\u201d or a \u201ccritical amplification loop\u201d for C3 and C5 activation","volume":"40","author":"Harrison","year":"2018","journal-title":"Semin Immunopathol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jri.2017.10.046","article-title":"The endometria of women with endometriosis exhibit dysfunctional expression of complement regulatory proteins during the mid secretory phase","volume":"125","author":"Palomino","year":"2018","journal-title":"J Reprod Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.fertnstert.2016.07.005","article-title":"Immune-inflammation gene signatures in endometriosis patients","volume":"106","author":"Ahn","year":"2016","journal-title":"Fertil Steril"},{"key":"B112","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.fertnstert.2012.04.047","article-title":"The ferroimmunomodulatory role of ectopic endometriotic stromal cells in ovarian endometriosis","volume":"98","author":"Kobayashi","year":"2012","journal-title":"Fertil Steril"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/130854","article-title":"Update on Biomarkers for the Detection of Endometriosis","volume":"2015","author":"Fassbender","year":"2015","journal-title":"BioMed Res Int"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(16)60185-1","article-title":"Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery","volume":"50","author":"Eisermann","year":"1988","journal-title":"Fertil Steril"},{"key":"B115","article-title":"Peritoneal fluid environment in endometriosis. Clinicopathological implications","volume":"55","author":"Bedaiwy","year":"2003","journal-title":"Minerva Ginecol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmq009","article-title":"Peripheral biomarkers of endometriosis: a systematic review","volume":"16","author":"May","year":"2010","journal-title":"Hum Reprod Update"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2014.1002732","article-title":"Chronic inflammation in endometriosis and endometriosis-associated ovarian cancer: New roles for the \u201cold\u201d complement pathway","volume":"4","author":"Edwards","year":"2015","journal-title":"Oncoimmunology"},{"key":"B118","doi-asserted-by":"crossref","DOI":"10.1101\/2020.11.19.389536","article-title":"Complement Component 3 expressed by the endometrial ectopic tissue is involved in the endometriotic lesion formation through mast cell activation","volume-title":"bioRxiv","author":"Agostinis","year":"2020"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2006.12.061","article-title":"Levels of complement components iC3b, C3c, C4, and SC5b-9 in peritoneal fluid and serum of infertile women with endometriosis","volume":"88","author":"Kabut","year":"2007","journal-title":"Fertil Steril"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-018-4754-0","article-title":"The role of complement components C1q, MBL and C1 inhibitor in pathogenesis of endometriosis","volume":"297","author":"Sikora","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2009.00728.x","article-title":"Plasma C3a-des-Arg levels in women with and without endometriosis","volume":"62","author":"Fassbender","year":"2009","journal-title":"Am J Reprod Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.03.017","article-title":"The link between immunity, autoimmunity and endometriosis: a literature update","volume":"17","author":"Zhang","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B123","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.molimm.2017.05.020","article-title":"The role of the complement system in hereditary angioedema","volume":"89","author":"Csuka","year":"2017","journal-title":"Mol Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1006450","article-title":"Hereditary angioedema\u2013therapies old and new","volume":"363","author":"Morgan","year":"2010","journal-title":"N Engl J Med"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1344","article-title":"Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria","volume":"25","author":"Rother","year":"2007","journal-title":"Nat Biotechnol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1172\/JCI105388","article-title":"Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody","volume":"45","author":"Rosse","year":"1966","journal-title":"J Clin Invest"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1172\/JCI105389","article-title":"Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. II. The role of complement components in the increased sensitivity of PNH red cells to immune lysis","volume":"45","author":"Rosse","year":"1966","journal-title":"J Clin Invest"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2019.07.030","article-title":"Compendium of current complement therapeutics","volume":"114","author":"Zelek","year":"2019","journal-title":"Mol Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-094136","article-title":"Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria","volume":"111","author":"Brodsky","year":"2008","journal-title":"Blood"},{"key":"B130","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.molimm.2018.06.008","article-title":"Developments in anti-complement therapy; from disease to clinical trial","volume":"102","author":"Harris","year":"2018","journal-title":"Mol Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4657","article-title":"Complement, a target for therapy in inflammatory and degenerative diseases","volume":"14","author":"Morgan","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"B132","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nrneph.2017.156","article-title":"The renaissance of complement therapeutics","volume":"14","author":"Ricklin","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195909","article-title":"Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action","volume":"13","author":"Sheridan","year":"2018","journal-title":"PLoS One"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1691","article-title":"Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization","volume":"28","author":"Igawa","year":"2010","journal-title":"Nat Biotechnol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41598-017-01087-7","article-title":"Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases","volume":"7","author":"Fukuzawa","year":"2017","journal-title":"Sci Rep"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209509","article-title":"Antibody engineering to generate SKY59, a long-acting anti-C5 recycling antibody","volume":"13","author":"Sampei","year":"2018","journal-title":"PLoS One"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01157","article-title":"Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMT","volume":"10","author":"Risitano","year":"2019","journal-title":"Front Immunol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.clim.2017.03.012","article-title":"Controlling the anaphylatoxin C5a in diseases requires a specifically targeted inhibition","volume":"180","author":"Riedemann","year":"2017","journal-title":"Clin Immunol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0320-7","article-title":"Complement as a target in COVID-19","volume":"20","author":"Risitano","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108450","article-title":"The first case of COVID-19 treated with the complement C3 inhibitor AMY-101","volume":"215","author":"Mastaglio","year":"2020","journal-title":"Clin Immunol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2020.152001","article-title":"Endothelial Injury and Thrombotic Microangiopathy in COVID-19: Treatment with the Lectin-Pathway Inhibitor Narsoplimab","volume":"225","author":"Rambaldi","year":"2020","journal-title":"Immunobiology"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2017.03.003","article-title":"Complement C3-Targeted Therapy: Replacing Long-Held Assertions with Evidence-Based Discovery","volume":"38","author":"Mastellos","year":"2017","journal-title":"Trends Immunol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-110827","article-title":"Inhibition of C3 with APL-2 Results in Normalisation of Markers of Intravascular and Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)","volume":"132","author":"Wong","year":"2018","journal-title":"Blood"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-119468","article-title":"Inhibition of C3 with APL-2 Results in Normalisation of Markers of Intravascular and Extravascular Hemolysis in Patients with Autoimmune Hemolytic Anemia (AIHA)","volume":"132","author":"Grossi","year":"2018","journal-title":"Blood"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.1251.1251","article-title":"APL-2, a Complement C3 Inhibitor for the Potential Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH): Phase I Data from Two Completed Studies in Healthy Volunteers","volume":"128","author":"Grossi","year":"2016","journal-title":"Blood"},{"key":"B146","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/ejh.13411","article-title":"A randomized, double-blind, single-dose, three-arm, parallel group study to determine pharmacokinetic similarity of ABP 959 and eculizumab (Soliris((R)) ) in healthy male subjects","volume":"105","author":"Chow","year":"2020","journal-title":"Eur J Haematol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.2196\/16664","article-title":"Evaluation of the Safety and Efficacy of Avacopan, a C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide\/Azathioprine: Protocol for a Randomized, Double-Blind, Active-Controlled, Phase 3 Trial","volume":"9","author":"Merkel","year":"2020","journal-title":"JMIR Res Protoc"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2018.1472234","article-title":"Avacopan in the treatment of ANCA-associated vasculitis","volume":"27","author":"Tesar","year":"2018","journal-title":"Expert Opin Invest Drugs"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016111179","article-title":"Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis","volume":"28","author":"Jayne","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164646","article-title":"Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study","volume":"11","author":"Bekker","year":"2016","journal-title":"PLoS One"},{"key":"B151","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2165\/11201100-000000000-00000","article-title":"Human C1-esterase inhibitor concentrate (Berinert)","volume":"23","author":"Keating","year":"2009","journal-title":"BioDrugs"},{"key":"B152","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13023-018-0797-3","article-title":"Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert(R)) in patients with hereditary angioedema: the SABHA study","volume":"13","author":"Zanichelli","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1159\/000477541","article-title":"Preventing Hereditary Angioedema Attacks in Children Using Cinryze(R): Interim Efficacy and Safety Phase 3 Findings","volume":"173","author":"Aygoren-Pursun","year":"2017","journal-title":"Int Arch Allergy Immunol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.2165\/11208390-000000000-00000","article-title":"Nanofiltered human C1 inhibitor concentrate (Cinryze(R)): in hereditary angioedema","volume":"25","author":"Lyseng-Williamson","year":"2011","journal-title":"BioDrugs"},{"key":"B155","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaip.2013.09.008","article-title":"Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedema","volume":"2","author":"Bernstein","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003399","article-title":"The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria","volume":"135","author":"Roth","year":"2020","journal-title":"Blood"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.2174\/0929867326666191001130342","article-title":"Discovery and Development of the Oral Complement Factor D Inhibitor Danicopan (ACH-4471)","volume":"27","author":"Wiles","year":"2020","journal-title":"Curr Med Chem"},{"key":"B158","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2020.261826","article-title":"Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria","volume-title":"Haematologica","author":"Risitano","year":"2020"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-019-00742-8","article-title":"Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab","volume":"58","author":"Wijnsma","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18877","article-title":"Clinical efficacy of complement C5a inhibition by IFX-1 in hidradenitis suppurativa: an open-label single-arm trial in patients not eligible for adalimumab","volume":"183","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Br J Dermatol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30341-6","article-title":"Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial","volume":"2","author":"Vlaar","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20546","article-title":"Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome","volume":"58","author":"Halstead","year":"2005","journal-title":"Ann Neurol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13063-017-1972-x","article-title":"A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial","volume":"18","author":"Kassimatis","year":"2017","journal-title":"Trials"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16305","article-title":"Successful treatment of a PNH patient non-responsive to eculizumab with the novel complement C5 inhibitor coversin (nomacopan)","volume":"188","author":"Schols","year":"2020","journal-title":"Br J Haematol"},{"key":"B165","doi-asserted-by":"crossref","DOI":"10.1111\/cei.13497","article-title":"MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab","volume-title":"Clin Exp Immunol","author":"Elhadad","year":"2020"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1159\/000508841","article-title":"Inhibition of the Lectin Pathway of the Complement System as a Novel Approach in the Management of IgA Vasculitis-Associated Nephritis","volume":"144","author":"Selvaskandan","year":"2020","journal-title":"Nephron"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231892","article-title":"Inhibition of complement pathway activation with Pozelimab, a fully human antibody to complement component C5","volume":"15","author":"Latuszek","year":"2020","journal-title":"PLoS One"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1808012","article-title":"Hereditary Angioedema","volume":"382","author":"Busse","year":"2020","journal-title":"N Engl J Med"},{"key":"B169","article-title":"Conestat alfa (ruconest): first recombinant c1 esterase inhibitor for the treatment of acute attacks in patients with hereditary angioedema","volume":"40","author":"Cruz","year":"2015","journal-title":"P T"},{"key":"B170","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.jid.2019.04.025","article-title":"Specific Inhibition of the Classical Complement Pathway Prevents C3 Deposition along the Dermal-Epidermal Junction in Bullous Pemphigoid","volume":"139","author":"Freire","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800998","article-title":"C1s Inhibition by BIVV009 (Sutimlimab) Prevents Complement-Enhanced Activation of Autoimmune Human B Cells In Vitro","volume":"202","author":"Nikitin","year":"2019","journal-title":"J Immunol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1111","article-title":"A Randomized, First-in-Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway","volume":"104","author":"Bartko","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"B173","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1182\/blood-2018-06-856930","article-title":"Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial","volume":"133","author":"Jager","year":"2019","journal-title":"Blood"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15922","article-title":"Intravenous immunoglobulin significantly reduces exposure of concomitantly administered anti-C5 monoclonal antibody tesidolumab","volume":"20","author":"Jordan","year":"2020","journal-title":"Am J Transplant"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00917","article-title":"Complement Inhibitor Therapy for Myasthenia Gravis","volume":"11","author":"Albazli","year":"2020","journal-title":"Front Immunol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1186\/s13063-020-04584-9","article-title":"ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial","volume":"21","author":"Wilkinson","year":"2020","journal-title":"Trials"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(16)55224-8","article-title":"The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis","volume":"58","author":"Oosterlynck","year":"1992","journal-title":"Fertil Steril"},{"key":"B178","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/s0015-0282(16)54414-8","article-title":"Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium","volume":"56","author":"Oosterlynck","year":"1991","journal-title":"Fertil Steril"},{"key":"B179","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/aji.12408","article-title":"Natural Killer Cells: Key Players in Endometriosis","volume":"74","author":"Thiruchelvam","year":"2015","journal-title":"Am J Reprod Immunol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2916070","article-title":"Decreased Cytotoxicity of Peripheral and Peritoneal Natural Killer Cell in Endometriosis","volume":"2016","author":"Jeung","year":"2016","journal-title":"BioMed Res Int"},{"key":"B181","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.3390\/jcm8091468","article-title":"NK Cells as Potential Targets for Immunotherapy in Endometriosis","volume":"8","author":"Sciezynska","year":"2019","journal-title":"J Clin Med"},{"key":"B182","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3390\/cancers11071040","article-title":"Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors","volume":"11","author":"Chen","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0206-4","article-title":"Human NK cells: surface receptors, inhibitory checkpoints, and translational applications","volume":"16","author":"Sivori","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01602","article-title":"Complement Receptor 3 Has Negative Impact on Tumor Surveillance through Suppression of Natural Killer Cell Function","volume":"8","author":"Liu","year":"2017","journal-title":"Front Immunol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat Immunol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-719757","article-title":"C1q and HMGB1 reciprocally regulate human macrophage polarization","volume":"128","author":"Son","year":"2016","journal-title":"Blood"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-014-0762-0","article-title":"Complement protein C1q promotes macrophage anti-inflammatory M2-like polarization during the clearance of atherogenic lipoproteins","volume":"63","author":"Spivia","year":"2014","journal-title":"Inflammation Res"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1311968111","article-title":"C1q as a unique player in angiogenesis with therapeutic implication in wound healing","volume":"111","author":"Bossi","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10346","article-title":"C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation","volume":"7","author":"Bulla","year":"2016","journal-title":"Nat Commun"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00865","article-title":"Is the Complement Protein C1q a Pro- or Anti-tumorigenic Factor? Bioinformatics Analysis Involving Human Carcinomas","volume":"10","author":"Mangogna","year":"2019","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.599117\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T12:17:24Z","timestamp":1697545044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.599117\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":190,"alternative-id":["10.3389\/fimmu.2020.599117"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.599117","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"article-number":"599117"}}